IBJNews

WellPoint says earnings could slightly exceed expectations

Back to TopCommentsE-mailPrintBookmark and Share

WellPoint Inc. said Tuesday that it expects 2012 earnings at the high end or slightly above a range that the health insurer reaffirmed last month.

The Indianapolis-based insurer also said it expects adjusted earnings per share to grow moderately this year, when the insurer plans to buy back stock and have a lower share count.

WellPoint shares were up 41 cents Tuesday morning, or less than 1 percent, to $60.16 each.

In December, WellPoint said it expected profit in the range of of $7.30 to $7.40 per share in 2012. That estimate doesn't count items such as investment gains and litigation or acquisition costs. The forecast also doesn't include costs tied to its acquisition of fellow insurer Amerigroup Corp., a $4.46 billion deal WellPoint recently completed.

Analysts expect, on average, 2012 earnings of $7.46 per share, according to FactSet.

WellPoint will release full fourth-quarter and 2012 financial results on Jan. 23.

WellPoint runs Blue Cross Blue Shield plans in several states and is the nation's second largest health insurer, trailing only UnitedHealth Group Inc.

The insurer will announce its forecast for 2013 later this quarter as well. Analysts and investors also are waiting for the announcement of a new CEO.

Former CEO Angela Braly resigned in August, a month after WellPoint cut its 2012 outlook and reported second-quarter earnings that fell, missing analyst expectations. WellPoint then beat Wall Street expectations in the third quarter, when the insurer recorded its first quarterly, year-over-year earnings increase since early 2011.

The insurer is slated to deliver a presentation Tuesday at the annual JP Morgan health care conference in San Francisco.

WellPoint competitor Aetna also will deliver a presentation Tuesday at the JP Morgan conference. Aetna on Monday reaffirmed its forecast for 2012 adjusted earnings of about $5.10 per share. The Hartford, Conn., insurer also expects 2013 earnings of at least $5.40 per share.

Analysts expect earnings of $5.15 per share in 2012 and $5.53 per share this year.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Thank you to the scientists who care enough to find a cure. We are so lucky that their intelligence has brought them to these understandings because it is through these understandings that we have new hope. Certainly the medicine will be expensive, these drugs usually are, especially the ones that are not mass produced. If I know anything from the walks that my town has put on for FA it is this: people care and people want to help. Donations and financial support can and will come to those who need it. All we need is a cure, the money will come. I mean, look at what these scientists have done thanks to the generosity of donors. 30 million dollars brings us here where we can talk about a drug's existence! There is so much to be frustrated about in this world, but this scientific break is not one of them. I am so happy for this new found hope. Thank you so much to the scientists who have been slaving away to help my friends with FA. We wish you speedy success in the time to come!

  2. I love tiny neighborhood bars-- when I travel city to city for work, it's my preference to find them. However, too many still having smoking inside. So I'm limited to bars in the cities that have smoking bans. I travel to Kokomo often, and I can promise, I'll be one of those people who visit the ma and pa bars once they're smoke free!

  3. I believe the issue with keystone & 96th was due to running out of funds though there were other factors. I just hope that a similar situation does not befall ST RD 37 where only half of the overhaul gets built.

  4. It's so great to see a country founded on freedom uphold the freedom for all people to work and patronize a public venue without risking their health! People do not go to bars to smoke, they can take it outside.

  5. So, Hurko, mass transit has not proven itself in Indy so we should build incredibly expensive train lines? How would that fix the lack of demand? And as far as those double decker buses to bus people in from suburbs, we can't fill up a regular sized buses now and have had to cancel lines and greatly subsidize others. No need for double decker buses there.

ADVERTISEMENT